New York Angels — 2019 Investments
1 investments dated 2019 · listed companies and verified rows first · show all
Front Range BiosciencesinSep 2019 · $8.5M
US-focused tissue culture cloning and biotech.
Boulder, US
Christopher Zalewski(Founder)inJonathan Vaught(Founder)inNick Hofmeister(Founder)
Co-investorsKEY Investment PartnersAFI Capital PartnersArcadian CapitalHALLEY Venture PartnersMilitello CapitalPhyto Partners+2 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.

